Free Trial
→ Only a handful of people know the setup that's defied these chaotic markets. (From WealthPress) (Ad) Buy CWK Stock  Free CWK Stock Alerts

Cushman & Wakefield (CWK) Financials

Cushman & Wakefield logo
$10.05 -0.08 (-0.79%)
Closing price 05/30/2025 03:59 PM Eastern
Extended Trading
$10.04 -0.02 (-0.15%)
As of 05/30/2025 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Cushman & Wakefield

Annual Income Statements for Cushman & Wakefield

This table shows Cushman & Wakefield's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Net Income / (Loss) Attributable to Common Shareholders		 131 -35 196 250 -221 0.20 -186 -221 -434
Consolidated Net Income / (Loss)		 131 -35 196 250 -221 0.20 -186 -221 -435
Net Income / (Loss) Continuing Operations		 131 -35 196 250 -221 0.20 -186 -221 -435
Total Pre-Tax Income 		176 -30 338 340 -177 43 -211 -342 -459
Total Revenue		 9,254 9,271 9,998 -158 7,688 8,603 7,993 6,742 -166
Net Interest Income / (Expense)		 -230 -281 -193 -180 -164 -151 -229 -183 -172
Total Interest Income		 0.00 -281 -193 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 230 0.00 0.00 180 164 151 229 183 172
Long-Term Debt Interest Expense		 230 - - 180 164 151 229 183 172
Total Non-Interest Income		 9,484 9,552 10,191 21 7,852 8,754 8,222 6,925 5.90
Net Realized & Unrealized Capital Gains on Investments		 37 58 85 21 8.30 2.60 1.90 1.40 5.90
Other Non-Interest Income		 9,447 9,494 10,106 - 7,844 8,751 8,220 6,924 -
Total Non-Interest Expense		 9,108 9,301 9,660 -497 7,865 8,564 8,207 7,095 295
Other Operating Expenses		 8,944 9,104 9,415 8,675 7,576 8,259 7,916 6,796 6,218
Depreciation Expense		 122 146 147 172 264 297 290 271 261
Impairment Charge		 41 38 8.90 45 57 7.70 1.50 29 32
Nonoperating Income / (Expense), net		 29 - - 1.20 - 3.50 3.50 11 2.40
Income Tax Expense		 45 5.40 142 90 44 43 -25 -121 -24
Basic Earnings per Share		 $0.57 ($0.16) $0.87 $1.12 ($1.00) $0.00 ($1.09) ($1.54) ($3.07)
Weighted Average Basic Shares Outstanding		 228.90M 226.90M 225.40M 223M 220.80M 217.70M 171.20M 143.90M 141.40M
Diluted Earnings per Share		 $0.56 ($0.16) $0.86 $1.10 ($1.00) $0.00 ($1.09) ($1.54) ($3.07)
Weighted Average Diluted Shares Outstanding		 232.80M 226.90M 228M 226.50M 220.80M 224.50M 171.20M 143.90M 141.40M
Weighted Average Basic & Diluted Shares Outstanding		 229.73M 227.33M 225.80M 224.55M 220.80M 217.70M 171.20M 143.90M 141.40M

Quarterly Income Statements for Cushman & Wakefield

This table shows Cushman & Wakefield's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 1.90 113 34 14 -29 70 -34 5.10 -76 30 24
Consolidated Net Income / (Loss)		 1.90 113 34 14 -29 70 -34 5.10 -76 30 24
Net Income / (Loss) Continuing Operations		 1.90 113 34 14 -29 70 -34 5.10 -76 30 24
Total Pre-Tax Income 		5.00 132 53 17 -27 70 -17 6.40 -89 89 50
Total Revenue		 2,243 2,583 2,301 2,232 2,138 2,512 2,213 2,361 2,184 7,752 -30
Net Interest Income / (Expense)		 -52 -56 -55 -61 -59 -57 -90 -58 -77 -53 -50
Total Interest Income		 0.00 - 0.00 0.00 0.00 -281 0.00 0.00 0.00 -193 0.00
Total Interest Expense		 52 56 55 61 59 -224 90 58 77 -140 50
Long-Term Debt Interest Expense		 52 56 55 61 59 - 90 58 77 - 50
Total Non-Interest Income		 2,296 2,639 2,356 2,292 2,197 2,569 2,303 2,419 2,261 7,805 20
Net Realized & Unrealized Capital Gains on Investments		 11 9.30 12 4.30 12 17 17 13 12 31 20
Other Non-Interest Income		 2,285 2,630 2,344 2,288 2,185 2,552 2,286 2,406 2,249 - -
Total Non-Interest Expense		 2,239 2,481 2,248 2,214 2,164 2,444 2,228 2,355 2,274 7,753 -112
Other Operating Expenses		 2,206 2,421 2,226 2,169 2,129 2,391 2,183 2,307 2,224 2,497 2,369
Depreciation Expense		 27 30 29 31 33 37 36 36 37 33 34
Impairment Charge		 6.50 4.60 14 17 5.00 15 9.20 7.00 7.20 5.80 0.60
Nonoperating Income / (Expense), net		 0.90 - - - - - -2.00 - - - -32
Income Tax Expense		 3.10 19 19 3.70 2.30 0.30 17 1.30 -13 59 26
Basic Earnings per Share		 $0.01 $0.49 $0.15 $0.06 ($0.13) $0.31 ($0.15) $0.02 ($0.34) $0.13 $0.11
Weighted Average Basic Shares Outstanding		 230.40M 228.90M 229.30M 229M 227.90M 226.90M 227.20M 227.10M 226.20M 225.40M 225.70M
Diluted Earnings per Share		 $0.01 $0.49 $0.14 $0.06 ($0.13) $0.31 ($0.15) $0.02 ($0.34) $0.12 $0.11
Weighted Average Diluted Shares Outstanding		 232.30M 232.80M 233.40M 231.50M 227.90M 226.90M 227.20M 227.10M 226.20M 228M 227.50M
Weighted Average Basic & Diluted Shares Outstanding		 231.29M 229.73M 229.49M 229.25M 229.05M 227.33M 227.25M 227.15M 227.06M 225.80M 225.76M

Annual Cash Flow Statements for Cushman & Wakefield

This table details how cash moves in and out of Cushman & Wakefield's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Net Change in Cash & Equivalents		 36 80 -151 -266 276 -95 506 29 -116
Net Cash From Operating Activities		 208 152 49 550 -38 269 -2.20 4.40 -335
Net Cash From Continuing Operating Activities		 208 152 49 550 -38 269 -2.20 4.40 -335
Net Income / (Loss) Continuing Operations		 131 -35 196 250 -221 0.20 -186 -221 -435
Consolidated Net Income / (Loss)		 131 -35 196 250 -221 0.20 -186 -221 -435
Provision For Loan Losses		 21 11 32 38 48 26 24 3.90 12
Depreciation Expense		 122 146 147 172 264 297 290 271 261
Amortization Expense		 94 105 112 114 128 122 13 17 13
Non-Cash Adjustments to Reconcile Net Income		 6.40 101 87 68 -25 49 138 42 38
Changes in Operating Assets and Liabilities, net		 -167 -175 -524 -92 -233 -226 -280 -107 -224
Net Cash From Investing Activities		 81 49 -121 -750 -258 -275 -218 -143 -138
Net Cash From Continuing Investing Activities		 81 49 -121 -750 -258 -275 -218 -143 -138
Purchase of Property, Leasehold Improvements and Equipment		 -41 -51 -51 -54 -41 -80 -84 -129 -77
Purchase of Investment Securities		 -507 -0.10 -139 -696 -123 -280 -49 -100 -57
Divestitures		 123 0.00 0.00 - - - - - 10
Sale and/or Maturity of Investments		 506 100 69 0.20 -94 86 -85 86 3.80
Net Cash From Financing Activities		 -253 -121 -79 -66 572 -90 726 168 357
Net Cash From Continuing Financing Activities		 -253 -121 -79 -66 572 -90 726 168 357
Issuance of Debt		 0.00 2,400 0.00 0.00 650 0.00 2,937 319 640
Repayment of Debt		 -229 -2,470 -44 -40 -43 -39 -3,168 -164 -320
Other Financing Activities, Net		 -25 -51 -35 -26 -35 -51 -62 -11 -2.90

Quarterly Cash Flow Statements for Cushman & Wakefield

This table details how cash moves in and out of Cushman & Wakefield's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 -183 26 197 22 -209 157 71 43 -191 212 -74
Net Cash From Operating Activities		 -162 115 196 22 -125 202 188 -17 -222 244 52
Net Cash From Continuing Operating Activities		 -162 115 196 22 -125 202 188 -17 -222 244 52
Net Income / (Loss) Continuing Operations		 1.90 113 34 14 -29 70 -34 5.10 -76 30 24
Consolidated Net Income / (Loss)		 1.90 113 34 14 -29 70 -34 5.10 -76 30 24
Provision For Loan Losses		 2.80 10 3.00 5.30 2.40 5.80 3.00 -0.10 1.90 14 7.90
Depreciation Expense		 27 30 29 31 33 37 36 36 37 33 34
Amortization Expense		 24 21 24 26 24 28 25 26 27 34 25
Non-Cash Adjustments to Reconcile Net Income		 3.90 16 -12 9.50 -6.80 26 23 23 29 12 30
Changes in Operating Assets and Liabilities, net		 -221 -74 118 -63 -148 36 135 -106 -240 122 -69
Net Cash From Investing Activities		 21 -33 57 68 -11 -31 -65 72 73 -13 -110
Net Cash From Continuing Investing Activities		 21 -33 57 68 -11 -31 -65 72 73 -13 -110
Purchase of Property, Leasehold Improvements and Equipment		 -4.60 -9.30 -9.40 -12 -11 -16 -14 -11 -10 -6.30 -14
Purchase of Investment Securities		 -4.80 -506 0.40 100 -100 4.90 41 -39 -6.70 -76 -16
Sale and/or Maturity of Investments		 30 481 -55 -20 100 -20 -92 122 90 69 -80
Net Cash From Financing Activities		 -41 -56 -57 -68 -73 -14 -52 -12 -43 -18 -16
Net Cash From Continuing Financing Activities		 -41 -56 -57 -68 -73 -14 -52 -12 -43 -18 -16
Repayment of Debt		 -25 -79 -50 -38 -62 -2.20 -1,431 -14 -1,024 -24 -6.70
Other Financing Activities, Net		 -16 23 -7.00 -30 -11 -12 -21 1.40 -19 5.70 -9.00

Annual Balance Sheets for Cushman & Wakefield

This table presents Cushman & Wakefield's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Total Assets		 7,549 7,774 7,949 7,890 7,338 7,163 6,546 5,793
Cash and Due from Banks		 793 768 645 771 1,075 813 895 406
Trading Account Securities		 724 708 677 641 115 7.90 8.70 7.90
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 136 164 173 195 236 299 314 304
Goodwill		 1,998 2,081 2,066 2,082 2,098 1,969 1,779 1,765
Intangible Assets		 690 806 875 922 991 1,063 1,128 1,306
Other Assets		 3,208 3,248 3,515 3,280 2,823 3,011 2,422 2,004
Total Liabilities & Shareholders' Equity		 7,549 7,774 7,949 7,890 7,338 7,163 6,546 5,793
Total Liabilities		 5,794 6,096 6,287 6,442 6,242 5,862 5,186 5,294
Short-Term Debt		 103 150 50 42 40 39 40 60
Accrued Interest Payable		 20 21 33 105 45 60 43 36
Other Short-Term Payables		 2,207 2,227 2,308 2,287 1,981 2,224 1,956 1,870
Long-Term Debt		 2,940 3,097 3,212 3,221 3,236 2,620 2,644 2,784
Other Long-Term Liabilities		 524 602 685 787 941 919 503 544
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,755 1,678 1,662 1,449 1,096 1,301 1,360 499
Total Preferred & Common Equity		 1,755 1,677 1,661 1,448 1,095 1,301 1,360 499
Total Common Equity		 1,755 1,677 1,661 1,448 1,095 1,301 1,360 499
Common Stock		 3,009 2,980 2,934 2,919 2,866 2,819 2,813 1,735
Retained Earnings		 -986 -1,117 -1,082 -1,278 -1,528 -1,297 -1,298 -1,149
Accumulated Other Comprehensive Income / (Loss)		 -269 -185 -191 -193 -243 -243 -154 -87
Noncontrolling Interest		 0.50 0.60 0.80 0.80 0.90 0.00 - -

Quarterly Balance Sheets for Cushman & Wakefield

This table presents Cushman & Wakefield's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 7,408 7,534 7,343 7,491 7,582 7,640 7,622 7,622
Cash and Due from Banks		 623 775 567 554 588 502 460 381
Trading Account Securities		 735 724 711 714 694 682 686 659
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 126 142 148 155 160 166 170 156
Goodwill		 2,021 2,049 2,024 2,064 2,052 2,073 2,067 2,021
Intangible Assets		 682 703 712 791 823 841 858 885
Other Assets		 3,220 3,141 3,181 3,213 3,265 3,376 3,382 3,519
Total Liabilities & Shareholders' Equity		 7,408 7,534 7,343 7,491 7,582 7,640 7,622 7,622
Total Liabilities		 5,631 5,831 5,704 5,866 6,011 6,018 6,042 6,044
Short-Term Debt		 109 96 142 125 119 37 34 46
Accrued Interest Payable		 31 31 28 20 7.00 55 6.90 27
Other Short-Term Payables		 2,063 2,114 1,966 2,035 2,091 2,031 2,080 2,150
Long-Term Debt		 2,911 2,997 3,002 3,066 3,125 3,226 3,228 3,212
Other Long-Term Liabilities		 517 593 567 620 669 668 694 609
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,777 1,703 1,640 1,625 1,572 1,622 1,580 1,578
Total Preferred & Common Equity		 1,776 1,702 1,639 1,625 1,571 1,621 1,579 1,577
Total Common Equity		 1,776 1,702 1,639 1,625 1,571 1,621 1,579 1,577
Common Stock		 3,015 2,994 2,982 2,978 2,967 2,953 2,939 2,924
Retained Earnings		 -984 -1,099 -1,133 -1,146 -1,187 -1,153 -1,158 -1,112
Accumulated Other Comprehensive Income / (Loss)		 -255 -192 -211 -207 -209 -178 -202 -235
Noncontrolling Interest		 0.50 0.60 0.60 0.60 0.50 0.60 0.50 0.70

Annual Metrics And Ratios for Cushman & Wakefield

This table displays calculated financial ratios and metrics derived from Cushman & Wakefield's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Growth Metrics		 - - - - - - - - -
Revenue Growth		 -0.18% -7.27% 6,415.60% -102.06% -10.63% 7.63% 18.55% 4,164.01% 0.00%
EBITDA Growth		 64.15% -62.98% -4.44% 190.15% -53.04% 419.61% 234.25% 65.07% 0.00%
EBIT Growth		 588.00% -108.88% -0.21% 291.79% -549.36% 118.34% 39.26% 23.52% 0.00%
NOPAT Growth		 620.68% -110.69% -21.16% 301.52% -67,414.69% 100.12% 39.26% 23.52% 0.00%
Net Income Growth		 470.90% -118.02% -21.44% 213.38% -110,350.00% 100.11% 16.04% 49.08% 0.00%
EPS Growth		 450.00% -118.60% -21.82% 210.00% 0.00% 100.00% 29.22% 49.84% 0.00%
Operating Cash Flow Growth		 36.66% 209.98% -91.06% 1,538.48% -114.18% 12,340.91% -150.00% 101.31% 0.00%
Free Cash Flow Firm Growth		 1,171.55% -40.13% 82.82% 82.88% -739.31% 109.81% 76.29% 0.00% 0.00%
Invested Capital Growth		 -2.57% 0.02% 4.50% 7.79% 10.35% -2.06% 20.98% 0.00% 0.00%
Revenue Q/Q Growth		 0.77% -36.11% 332.69% -101.84% -4.21% 2.47% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 5.87% -8.98% -26.91% 21.62% -8.27% 31.73% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 30.95% -206.12% -38.65% 59.09% 0.28% 192.69% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 23.97% -165.49% -49.01% 223.95% 0.28% 100.62% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 48.87% 53.05% -37.13% 225.10% -15.99% 100.96% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 47.37% 54.29% -38.13% 233.33% -16.28% 100.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 -29.54% -21.34% -53.06% 26.44% -125.92% 529.51% -101.06% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 119.50% -276.14% -131.35% 8.80% 2.60% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.04% 2.26% 1.81% 4.68% 1.09% 1.57% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - -
EBITDA Margin		 3.92% 2.38% 5.97% 0.00% 2.80% 5.33% 1.10% -0.97% 0.00%
EBIT Margin		 1.58% -0.32% 3.38% 0.00% -2.30% 0.46% -2.68% -5.23% 0.00%
Profit (Net Income) Margin		 1.42% -0.38% 1.96% 0.00% -2.87% 0.00% -2.32% -3.28% 0.00%
Tax Burden Percent		 74.69% 118.00% 58.11% 73.55% 124.86% 0.47% 88.14% 64.75% 94.70%
Interest Burden Percent		 120.08% 100.00% 100.00% 100.35% 100.00% 108.91% 98.37% 96.88% 99.48%
Effective Tax Rate		 25.31% 0.00% 41.89% 26.45% 0.00% 99.53% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 2.25% -0.43% 4.08% 0.00% -2.97% 0.00% -4.06% -14.78% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 2.95% -0.87% 4.08% 0.00% -6.23% 0.01% -5.36% -12.97% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 5.40% -1.69% 8.55% 0.00% -15.43% 0.01% -15.92% -73.85% 0.00%
Return on Equity (ROE)		 7.65% -2.12% 12.63% 19.65% -18.40% 0.02% -19.98% -88.63% 0.00%
Cash Return on Invested Capital (CROIC)		 4.85% -0.45% -0.33% -2.01% -12.81% 2.09% -23.05% -214.78% 0.00%
Operating Return on Assets (OROA)		 1.91% -0.38% 4.27% 0.00% -2.44% 0.57% -3.47% -6.09% 0.00%
Return on Assets (ROA)		 1.71% -0.45% 2.48% 0.00% -3.04% 0.00% -3.01% -3.82% 0.00%
Return on Common Equity (ROCE)		 7.65% -2.12% 12.62% 19.64% -18.39% 0.02% -19.98% -88.63% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 7.48% -2.11% 11.82% 17.27% -20.14% 0.02% -13.66% -44.31% 0.00%
Net Operating Profit after Tax (NOPAT)		 109 -21 196 249 -124 0.18 -150 -247 -323
NOPAT Margin		 1.18% -0.23% 1.96% 0.00% -1.61% 0.00% -1.88% -3.66% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -0.70% 0.44% 0.00% -0.03% 3.26% 0.00% 1.30% -1.80% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 98.42% 100.32% 96.62% 0.00% 102.30% 99.54% 102.68% 105.23% 0.00%
Earnings before Interest and Taxes (EBIT)		 146 -30 338 339 -177 39 -214 -353 -461
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 363 221 597 624 215 458 88 -66 -188
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 1.71 1.46 1.69 3.43 3.00 3.44 2.30 1.53 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.32 0.26 0.28 0.00 0.43 0.52 0.39 0.11 0.00
Price to Earnings (P/E)		 22.86 0.00 14.32 19.88 0.00 22,399.21 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 4.37% 0.00% 6.98% 5.03% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.09 1.00 1.10 1.58 1.26 1.60 1.22 0.96 0.00
Enterprise Value to Revenue (EV/Rev)		 0.57 0.53 0.54 0.00 0.71 0.74 0.61 0.48 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 14.48 22.34 9.10 11.95 25.50 13.80 55.73 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 35.87 0.00 16.07 22.03 0.00 160.97 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 48.03 0.00 27.65 29.96 0.00 34,448.24 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 25.25 32.42 110.61 13.58 0.00 23.49 0.00 727.93 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 22.28 0.00 0.00 0.00 0.00 75.78 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 1.73 1.93 1.96 2.25 2.99 2.04 1.97 5.69 0.00
Long-Term Debt to Equity		 1.67 1.85 1.93 2.22 2.95 2.01 1.94 5.57 0.00
Financial Leverage		 1.83 1.95 2.10 2.57 2.48 2.01 2.97 5.69 0.00
Leverage Ratio		 4.46 4.71 5.09 5.99 6.05 5.15 6.64 11.60 0.00
Compound Leverage Factor		 5.36 4.71 5.09 6.01 6.05 5.61 6.53 11.24 0.00
Debt to Total Capital		 63.42% 65.93% 66.24% 69.25% 74.93% 67.15% 66.37% 85.06% 0.00%
Short-Term Debt to Total Capital		 2.15% 3.04% 1.01% 0.90% 0.91% 0.99% 0.99% 1.78% 0.00%
Long-Term Debt to Total Capital		 61.26% 62.89% 65.23% 68.35% 74.03% 66.15% 65.38% 83.28% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.01% 0.01% 0.02% 0.02% 0.02% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 36.57% 34.06% 33.74% 30.73% 25.04% 32.85% 33.63% 14.94% 0.00%
Debt to EBITDA		 8.39 14.70 5.47 5.23 15.22 5.80 30.43 -43.28 0.00
Net Debt to EBITDA		 6.20 11.22 4.39 3.99 10.23 4.03 20.28 -37.11 0.00
Long-Term Debt to EBITDA		 8.11 14.02 5.38 5.16 15.04 5.72 29.98 -42.37 0.00
Debt to NOPAT		 27.83 -154.60 16.61 13.10 -26.50 14,482.30 -17.89 -11.51 0.00
Net Debt to NOPAT		 20.57 -118.04 13.32 10.00 -17.80 10,054.19 -11.92 -9.87 0.00
Long-Term Debt to NOPAT		 26.88 -147.47 16.35 12.93 -26.17 14,268.30 -17.63 -11.27 0.00
Noncontrolling Interest Sharing Ratio		 0.03% 0.04% 0.05% 0.07% 0.04% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 236 -22 -16 -91 -534 83 -851 -3,590 0.00
Operating Cash Flow to CapEx		 507.32% 298.43% 96.84% 1,021.38% -93.17% 335.37% -2.61% 3.41% -433.51%
Free Cash Flow to Firm to Interest Expense		 1.03 0.00 0.00 -0.51 -3.26 0.55 -3.72 -19.61 0.00
Operating Cash Flow to Interest Expense		 0.90 0.00 0.00 3.06 -0.23 1.79 -0.01 0.02 -1.95
Operating Cash Flow Less CapEx to Interest Expense		 0.73 0.00 0.00 2.76 -0.48 1.26 -0.38 -0.68 -2.40
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 1.21 1.18 1.26 0.00 1.06 1.26 1.30 1.16 0.00
Fixed Asset Turnover		 61.73 55.12 54.45 0.00 28.72 28.06 25.86 22.16 0.00
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 4,798 4,925 4,924 4,712 4,371 3,961 4,044 3,343 0.00
Invested Capital Turnover		 1.90 1.88 2.08 0.00 1.85 2.15 2.16 4.03 0.00
Increase / (Decrease) in Invested Capital		 -126 1.00 212 341 410 -83 701 3,343 0.00
Enterprise Value (EV)		 5,252 4,934 5,431 7,463 5,488 6,326 4,915 3,203 0.00
Market Capitalization		 3,002 2,454 2,813 4,970 3,287 4,480 3,126 765 765
Book Value per Share		 $7.65 $7.38 $7.36 $6.48 $4.94 $5.94 $6.30 $3.47 $0.00
Tangible Book Value per Share		 ($4.07) ($5.32) ($5.66) ($6.96) ($9.00) ($7.90) ($7.16) ($17.87) $0.00
Total Capital		 4,798 4,925 4,924 4,712 4,371 3,961 4,044 3,343 0.00
Total Debt		 3,043 3,247 3,262 3,263 3,275 2,660 2,684 2,844 0.00
Total Long-Term Debt		 2,940 3,097 3,212 3,221 3,236 2,620 2,644 2,784 0.00
Net Debt		 2,250 2,479 2,617 2,492 2,201 1,846 1,789 2,438 0.00
Capital Expenditures (CapEx)		 41 51 51 54 41 80 84 129 77
Net Nonoperating Expense (NNE)		 -22 14 0.00 -0.88 97 -0.02 36 -26 112
Net Nonoperating Obligations (NNO)		 3,043 3,247 3,262 3,263 3,275 2,660 2,684 2,844 0.00
Total Depreciation and Amortization (D&A)		 216 251 259 286 392 419 303 287 273
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.57 ($0.16) $0.87 $1.12 ($1.00) $0.00 ($1.09) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 228.90M 226.90M 225.40M 223M 222.18M 219.89M 216.60M 0.00 0.00
Adjusted Diluted Earnings per Share		 $0.56 ($0.16) $0.86 $1.10 ($1.00) $0.00 ($1.09) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 232.80M 226.90M 228M 226.50M 220.80M 224.50M 216.60M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($1.00) $0.00 ($1.09) $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 229.73M 227.33M 225.80M 224.55M 220.80M 217.70M 171.20M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 140 14 253 -6,624 -106 33 -149 -227 -4,651
Normalized NOPAT Margin		 1.51% 0.16% 2.53% 0.00% -1.38% 0.38% -1.86% -3.37% 0.00%
Pre Tax Income Margin		 1.90% -0.32% 3.38% 0.00% -2.30% 0.50% -2.64% -5.07% 0.00%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 0.64 0.00 0.00 1.89 -1.08 0.26 -0.94 -1.93 -2.69
NOPAT to Interest Expense		 0.48 0.00 0.00 1.39 -0.75 0.00 -0.66 -1.35 -1.88
EBIT Less CapEx to Interest Expense		 0.46 0.00 0.00 1.59 -1.33 -0.27 -1.30 -2.63 -3.14
NOPAT Less CapEx to Interest Expense		 0.30 0.00 0.00 1.09 -1.01 -0.53 -1.02 -2.05 -2.33
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Cushman & Wakefield

This table displays calculated financial ratios and metrics derived from Cushman & Wakefield's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 4.94% 2.83% 3.99% -5.48% -2.13% -67.59% 7,379.93% 8,354.90% -5.22% 218.49% -101.33%
EBITDA Growth		 96.04% 15.14% 131.37% 9.14% 215.23% 102.44% -67.33% -68.24% -114.46% -77.01% -11.75%
EBIT Growth		 114.54% 50.81% 446.41% 168.75% 70.29% 9,828.57% -118.73% -95.68% -181.83% -100.33% -7.05%
NOPAT Growth		 107.89% 61.75% 414.66% 164.71% 70.29% 134.23% -127.48% -95.64% -195.81% -80.97% -40.88%
Net Income Growth		 106.60% 61.75% 199.41% 164.71% 62.30% 134.23% -241.84% -94.75% -267.91% -79.56% -65.21%
EPS Growth		 107.69% 58.06% 193.33% 200.00% 61.76% 158.33% -236.36% -95.35% -270.00% -81.54% -63.33%
Operating Cash Flow Growth		 -29.50% -43.08% 4.25% 229.76% 43.52% -16.95% 263.83% 80.93% -40.01% -18.55% -68.36%
Free Cash Flow Firm Growth		 325.54% 247.82% 445.92% 413.55% 105.99% 137.74% 103.27% 87.44% 70.18% 0.88% -166.36%
Invested Capital Growth		 -0.42% -2.57% -0.40% -2.09% -0.51% 0.02% -0.42% 0.87% 0.91% 4.50% 7.45%
Revenue Q/Q Growth		 -13.16% 12.25% 3.13% 4.38% -55.45% 13.52% -6.26% 8.08% -71.82% 25,599.67% -6.29%
EBITDA Q/Q Growth		 -64.36% 43.97% 43.51% 150.85% -77.79% 189.32% -32.30% 364.84% -116.56% -53.31% -34.19%
EBIT Q/Q Growth		 -96.01% 93.77% 208.14% 164.91% -138.91% 545.10% -339.06% 107.17% -201.02% -100.86% -44.80%
NOPAT Q/Q Growth		 -98.62% 235.01% 149.63% 172.78% -126.58% 751.73% -310.00% 108.17% -310.72% -23.54% -66.68%
Net Income Q/Q Growth		 -98.32% 235.01% 149.63% 146.88% -141.26% 305.90% -764.71% 106.68% -356.38% 24.69% -75.41%
EPS Q/Q Growth		 -97.96% 250.00% 133.33% 146.15% -141.94% 306.67% -850.00% 105.88% -383.33% 9.09% -74.42%
Operating Cash Flow Q/Q Growth		 -240.63% -41.25% 799.54% 117.43% -161.81% 7.60% 1,219.64% 92.42% -190.89% 371.37% 158.68%
Free Cash Flow Firm Q/Q Growth		 -90.82% 352.36% -54.28% 1,722.05% -90.77% 610.01% 126.26% 65.17% 41.94% 38.44% -0.81%
Invested Capital Q/Q Growth		 -0.05% 0.04% 0.28% -0.69% -2.20% 2.26% -1.42% 0.91% -1.67% 1.81% -0.15%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 2.43% 5.92% 4.61% 3.32% 1.38% 5.29% 2.07% 2.87% -1.17% 0.85% 0.00%
EBIT Margin		 0.18% 3.98% 2.30% 0.77% -1.24% 2.71% -0.69% 0.27% -4.08% -0.01% 0.00%
Profit (Net Income) Margin		 0.08% 4.37% 1.46% 0.61% -1.35% 2.78% -1.53% 0.22% -3.50% 0.38% 0.00%
Tax Burden Percent		 38.00% 85.47% 63.58% 78.49% 108.68% 99.57% 195.95% 79.69% 85.65% 33.56% 47.70%
Interest Burden Percent		 121.95% 128.63% 100.00% 100.00% 100.00% 102.94% 113.07% 100.00% 100.00% -12,685.71% 61.32%
Effective Tax Rate		 62.00% 14.53% 36.42% 21.51% 0.00% 0.43% 0.00% 20.31% 0.00% 66.44% 52.30%
Return on Invested Capital (ROIC)		 0.14% 8.32% 2.80% 1.14% -1.66% 5.23% -1.46% 0.54% -5.86% 0.80% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.15% 8.32% 2.80% 1.14% -1.98% 5.23% -2.17% 0.54% -6.29% 0.80% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.27% 15.24% 5.42% 2.24% -3.98% 10.19% -4.48% 1.11% -13.15% 1.67% 0.00%
Return on Equity (ROE)		 0.40% 23.56% 8.21% 3.37% -5.63% 15.42% -5.93% 1.65% -19.01% 2.47% 22.20%
Cash Return on Invested Capital (CROIC)		 3.33% 4.85% 2.23% 2.54% 0.77% -0.45% 0.26% -1.23% 0.64% -0.33% 1.07%
Operating Return on Assets (OROA)		 0.23% 4.80% 2.80% 0.94% -1.51% 3.20% -1.32% 0.43% -5.25% -0.01% 0.00%
Return on Assets (ROA)		 0.11% 5.28% 1.78% 0.73% -1.64% 3.28% -2.92% 0.34% -4.49% 0.49% 0.00%
Return on Common Equity (ROCE)		 0.40% 23.55% 8.21% 3.37% -5.63% 15.42% -5.93% 1.65% -19.00% 2.47% 22.19%
Return on Equity Simple (ROE_SIMPLE)		 9.12% 0.00% 5.18% 1.26% 0.75% 0.00% -4.80% -1.09% 4.72% 0.00% 19.80%
Net Operating Profit after Tax (NOPAT)		 1.56 113 34 14 -19 70 -11 5.10 -62 30 39
NOPAT Margin		 0.07% 4.37% 1.46% 0.61% -0.87% 2.78% -0.48% 0.22% -2.86% 0.38% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -0.01% 0.00% 0.00% 0.00% 0.32% 0.00% 0.71% 0.00% 0.43% 0.00% 0.46%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 99.82% 96.02% 97.70% 99.23% 101.24% 97.29% 100.69% 99.73% 104.08% 100.01% 0.00%
Earnings before Interest and Taxes (EBIT)		 4.10 103 53 17 -27 68 -15 6.40 -89 -0.70 82
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 55 153 106 74 30 133 46 68 -26 66 141
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.32 1.71 1.84 1.45 1.46 1.46 1.10 1.15 1.51 1.69 1.64
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.25 0.32 0.34 0.26 0.26 0.26 0.12 0.15 0.24 0.28 0.00
Price to Earnings (P/E)		 14.49 22.86 35.43 115.64 194.84 0.00 0.00 0.00 31.95 14.32 8.27
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 6.90% 4.37% 2.82% 0.86% 0.51% 0.00% 0.00% 0.00% 3.13% 6.98% 12.09%
Enterprise Value to Invested Capital (EV/IC)		 0.99 1.09 1.13 1.04 1.04 1.00 0.91 0.95 1.07 1.10 1.13
Enterprise Value to Revenue (EV/Rev)		 0.51 0.57 0.59 0.55 0.54 0.53 0.30 0.38 0.52 0.54 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 12.19 14.48 15.89 17.57 18.17 22.34 18.08 13.69 10.73 9.10 6.69
Enterprise Value to EBIT (EV/EBIT)		 26.55 35.87 48.69 114.00 153.37 0.00 0.00 52.97 22.65 16.07 9.91
Enterprise Value to NOPAT (EV/NOPAT)		 33.97 48.03 61.72 240.72 411.07 0.00 0.00 0.00 69.56 27.65 14.18
Enterprise Value to Operating Cash Flow (EV/OCF)		 27.73 25.25 18.44 17.27 20.17 32.42 22.67 80.89 0.00 110.61 52.22
Enterprise Value to Free Cash Flow (EV/FCFF)		 29.64 22.28 50.68 40.38 135.18 0.00 351.26 0.00 167.18 0.00 109.05
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.70 1.73 1.82 1.92 1.96 1.93 2.06 2.01 2.07 1.96 2.06
Long-Term Debt to Equity		 1.64 1.67 1.76 1.83 1.89 1.85 1.99 1.99 2.04 1.93 2.04
Financial Leverage		 1.83 1.83 1.94 1.96 2.01 1.95 2.06 2.03 2.09 2.10 2.32
Leverage Ratio		 4.38 4.46 4.62 4.59 4.72 4.71 4.83 4.79 4.93 5.09 5.36
Compound Leverage Factor		 5.34 5.74 4.62 4.59 4.72 4.85 5.46 4.79 4.93 -645.96 3.29
Debt to Total Capital		 62.95% 63.42% 64.49% 65.72% 66.25% 65.93% 67.37% 66.80% 67.37% 66.24% 67.37%
Short-Term Debt to Total Capital		 2.26% 2.15% 2.01% 2.96% 2.60% 3.04% 2.47% 0.75% 0.70% 1.01% 0.96%
Long-Term Debt to Total Capital		 60.69% 61.26% 62.48% 62.76% 63.66% 62.89% 64.90% 66.05% 66.68% 65.23% 66.41%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.02% 0.01%
Common Equity to Total Capital		 37.04% 36.57% 35.49% 34.27% 33.74% 34.06% 32.62% 33.19% 32.62% 33.74% 32.62%
Debt to EBITDA		 7.75 8.39 9.03 11.14 11.56 14.70 13.37 9.67 6.75 5.47 3.99
Net Debt to EBITDA		 6.15 6.20 6.77 9.13 9.56 11.22 10.94 8.19 5.80 4.39 3.52
Long-Term Debt to EBITDA		 7.48 8.11 8.75 10.64 11.11 14.02 12.88 9.57 6.68 5.38 3.93
Debt to NOPAT		 21.62 27.83 35.07 152.59 261.55 -154.60 -410.13 -185.40 43.78 16.61 8.46
Net Debt to NOPAT		 17.16 20.57 26.28 125.05 216.18 -118.04 -335.76 -156.86 37.61 13.32 7.47
Long-Term Debt to NOPAT		 20.84 26.88 33.98 145.71 251.30 -147.47 -395.09 -183.32 43.33 16.35 8.34
Noncontrolling Interest Sharing Ratio		 0.03% 0.03% 0.03% 0.04% 0.03% 0.04% 0.04% 0.04% 0.04% 0.05% 0.05%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 22 239 53 116 6.35 69 9.69 -37 -106 -182 -296
Operating Cash Flow to CapEx		 -3,521.74% 1,238.71% 2,086.17% 184.75% -1,191.43% 1,249.38% 1,324.65% -158.49% -2,215.00% 3,868.25% 371.94%
Free Cash Flow to Firm to Interest Expense		 0.42 4.31 0.96 1.90 0.11 0.00 0.11 -0.64 -1.38 0.00 -5.88
Operating Cash Flow to Interest Expense		 -3.10 2.08 3.57 0.36 -2.13 0.00 2.10 -0.29 -2.88 0.00 1.03
Operating Cash Flow Less CapEx to Interest Expense		 -3.19 1.91 3.40 0.16 -2.31 0.00 1.94 -0.47 -3.01 0.00 0.75
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.26 1.21 1.22 1.21 1.22 1.18 1.91 1.60 1.28 1.26 0.00
Fixed Asset Turnover		 66.59 61.73 60.83 57.89 56.80 55.12 91.72 70.78 54.56 54.45 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 4,796 4,798 4,796 4,783 4,816 4,925 4,816 4,885 4,841 4,924 4,836
Invested Capital Turnover		 1.95 1.90 1.91 1.88 1.91 1.88 3.01 2.52 2.05 2.08 0.00
Increase / (Decrease) in Invested Capital		 -20 -126 -19 -102 -25 1.00 -20 42 44 212 335
Enterprise Value (EV)		 4,744 5,252 5,443 4,959 5,015 4,934 4,387 4,619 5,183 5,431 5,462
Market Capitalization		 2,348 3,002 3,125 2,382 2,377 2,454 1,731 1,857 2,380 2,813 2,584
Book Value per Share		 $7.73 $7.65 $7.43 $7.16 $7.13 $7.38 $6.92 $7.14 $6.99 $7.36 $6.99
Tangible Book Value per Share		 ($4.03) ($4.07) ($4.58) ($4.79) ($5.40) ($5.32) ($5.74) ($5.69) ($5.96) ($5.66) ($5.89)
Total Capital		 4,796 4,798 4,796 4,783 4,816 4,925 4,816 4,885 4,841 4,924 4,836
Total Debt		 3,019 3,043 3,093 3,143 3,191 3,247 3,244 3,263 3,262 3,262 3,258
Total Long-Term Debt		 2,911 2,940 2,997 3,002 3,066 3,097 3,125 3,226 3,228 3,212 3,212
Net Debt		 2,396 2,250 2,318 2,576 2,637 2,479 2,656 2,761 2,802 2,617 2,877
Capital Expenditures (CapEx)		 4.60 9.30 9.40 12 11 16 14 11 10 6.30 14
Net Nonoperating Expense (NNE)		 -0.34 0.00 0.00 0.00 10 0.00 23 0.00 14 0.00 15
Net Nonoperating Obligations (NNO)		 3,019 3,043 3,093 3,143 3,191 3,247 3,244 3,263 3,262 3,262 3,258
Total Depreciation and Amortization (D&A)		 50 50 53 57 56 65 61 61 64 66 59
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.01 $0.49 $0.15 $0.06 ($0.13) $0.31 ($0.15) $0.02 ($0.34) $0.13 $0.11
Adjusted Weighted Average Basic Shares Outstanding		 230.40M 228.90M 229.30M 229M 227.90M 226.90M 227.20M 227.10M 226.20M 225.40M 225.70M
Adjusted Diluted Earnings per Share		 $0.01 $0.49 $0.14 $0.06 ($0.13) $0.31 ($0.15) $0.02 ($0.34) $0.12 $0.11
Adjusted Weighted Average Diluted Shares Outstanding		 232.30M 232.80M 233.40M 231.50M 227.90M 226.90M 227.20M 227.10M 226.20M 228M 227.50M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 231.29M 229.73M 229.49M 229.25M 229.05M 227.33M 227.25M 227.15M 227.06M 225.80M 225.76M
Normalized Net Operating Profit after Tax (NOPAT)		 7.42 117 30 25 -16 84 -4.27 15 -53 66 -1,703
Normalized NOPAT Margin		 0.33% 4.52% 1.28% 1.10% -0.76% 3.36% -0.19% 0.61% -2.44% 0.85% 0.00%
Pre Tax Income Margin		 0.22% 5.11% 2.30% 0.77% -1.24% 2.79% -0.78% 0.27% -4.08% 1.15% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.08 1.85 0.97 0.28 -0.45 0.00 -0.17 0.11 -1.16 0.00 1.62
NOPAT to Interest Expense		 0.03 2.03 0.61 0.22 -0.32 0.00 -0.12 0.09 -0.81 0.00 0.77
EBIT Less CapEx to Interest Expense		 -0.01 1.68 0.79 0.09 -0.63 0.00 -0.33 -0.07 -1.29 0.00 1.35
NOPAT Less CapEx to Interest Expense		 -0.06 1.87 0.44 0.03 -0.49 0.00 -0.28 -0.10 -0.94 0.00 0.50
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Cushman & Wakefield's Financials

When does Cushman & Wakefield's financial year end?

According to the most recent income statement we have on file, Cushman & Wakefield's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Cushman & Wakefield's net income changed over the last 8 years?

Cushman & Wakefield's net income appears to be on a downward trend, with a most recent value of $131.30 million in 2024, falling from -$434.60 million in 2016. The previous period was -$35.40 million in 2023. Find out what analysts predict for Cushman & Wakefield in the coming months.

How has Cushman & Wakefield revenue changed over the last 8 years?

Over the last 8 years, Cushman & Wakefield's total revenue changed from -$165.90 million in 2016 to $9.25 billion in 2024, a change of -5,678.1%.

How much debt does Cushman & Wakefield have?

Cushman & Wakefield's total liabilities were at $5.79 billion at the end of 2024, a 5.0% decrease from 2023, and a 9.4% increase since 2017.

How much cash does Cushman & Wakefield have?

In the past 7 years, Cushman & Wakefield's cash and equivalents has ranged from $405.60 million in 2017 to $1.07 billion in 2020, and is currently $793.30 million as of their latest financial filing in 2024.

How has Cushman & Wakefield's book value per share changed over the last 8 years?

Over the last 8 years, Cushman & Wakefield's book value per share changed from 0.00 in 2016 to 7.65 in 2024, a change of 764.7%.


Related Companies

This page (NYSE:CWK) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
As Bitcoin supply vanishes, this Trump-aligned token could explode
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored